5/13/2020 | IG | Fitch ups, withdraws Allergan
|
5/13/2020 | IGLM | AbbVie gets tenders for $13.99 billion, €3.06 billion Allergan notes
|
5/5/2020 | IGLM | AbbVie extends exchange for Allergan notes for expected last time
|
4/27/2020 | IGLM | AbbVie extends exchange offers for Allergan notes by one more week
|
4/20/2020 | IGLM | AbbVie extends exchange offers for Allergan notes by one more week
|
4/6/2020 | IGLM | AbbVie extends exchange offers for Allergan notes by two more weeks
|
3/23/2020 | IGLM | Abbvie extends exchange offers for Allergan notes by two more weeks
|
2/24/2020 | IGLM | AbbVie extends exchange offers for Allergan notes by two more weeks
|
1/27/2020 | IGLM | AbbVie extends exchange offers for Allergan notes by one more month
|
12/20/2019 | IGLM | AbbVie extends exchange offers for Allergan notes by one more month
|
11/18/2019 | IGLM | AbbVie extends exchange offers for Allergan notes to Dec. 31
|
11/7/2019 | IGLM | AbbVie announces early participation results of exchange offer for 18 series of Allergan notes
|
10/25/2019 | IGLM | AbbVie launches exchange offer for 18 series of Allergan notes
|
6/25/2019 | BKIG | Moody’s might up Allergan plc
|
11/8/2018 | CVIG | Moody's rates Allergan notes Baa3
|
11/24/2015 | CVIG | Fitch puts Allergan on positive watch
|
11/23/2015 | CVIG | Moody’s reviews Allergan, Actavis, Forest
|
5/12/2015 | BKCVIG | S&P lowers Allergan
|
4/22/2015 | IG | Moody’s drops Allergan to Baa3
|
3/17/2015 | BKCVIG | Fitch cuts Allergan, affirms Actavis
|
3/3/2015 | IG | Market Commentary: Actavis megadeal prices; Exxon upsizes; Exxon trades; AT&T firms; Verizon mixed
|
3/3/2015 | IG | New Issue: Actavis prices $21 billion 10-part offering of senior notes
|
3/3/2015 | IG | Actavis sets guidance for 10-part bond offering; pricing Tuesday; around $20 billion size eyed
|
3/2/2015 | IG | Market Commentary: MetLife, Discover, American Airlines price; Actavis jumbo bond on deck; Discover, MetLife firm
|
3/2/2015 | IG | Actavis to price around $20 billion of bonds in nine parts Tuesday to fund Allergan acquisition
|
11/17/2014 | BKBWIG | Actavis plans to issue $27.5 billion of new debt at an average of 4.25% to fund Allergan merger
|
9/25/2014 | IG | Moody’s reviews Allergan
|
4/23/2014 | CVIG | S&P: Allergan on watch
|
4/23/2014 | CVIG | Fitch puts Allergan on watch
|
4/22/2014 | IG | Moody's revises Allergan outlook to negative
|
3/11/2013 | IG | Market Commentary: Midday Commentary: Secondary trading better; Allergan spreads continue to tighten
|
3/8/2013 | IG | Market Commentary: Midday Commentary: Secondary sees Allergan notes trading better compared to new issue spreads
|
3/8/2013 | IG | Market Commentary: Scotiabank, Prospect Capital cap busy week of issuance; Avon, Allergan notes trade better
|
3/7/2013 | CVIG | Moody's: Allergan notes A3
|
3/7/2013 | IG | Allergan prepares Thursday note sale in five-, 10-year maturities
|
3/7/2013 | IG | New Issue: Allergan sells $600 million of notes in five-, 10-year maturities
|
3/7/2013 | IG | Market Commentary: Avon, Progress Energy sell in 'fatigued' primary; new issues trade better during strong session
|
3/7/2013 | CVIG | Fitch rates Allergan notes A+
|
3/7/2013 | CVIG | S&P rates Allergan notes A+
|
1/24/2013 | CVIG | Moody's: Allergan unchanged
|
1/23/2013 | CVIG | Fitch: Allergan unchanged
|
8/6/2012 | CVIGPF | Allergan files automatic shelf for debt securities, preferreds, stock
|
5/31/2012 | BKCVIG | S&P lifts health companies
|
3/13/2012 | CVIG | Fitch upgrades Allergan
|
3/16/2011 | CVIG | Fitch ups Allergan
|
9/7/2010 | IG | New Issue: Allergan sells $650 million 3.375% 10-year senior notes to yield Treasuries plus 80 bps
|
9/7/2010 | IG | Market Commentary: Dell, Home Depot among issuers as primary bursts with deals amid low rates; bonds trade well
|
9/7/2010 | CVIG | S&P rates Allergan notes A+
|
9/7/2010 | CVIG | Moody's rates Allergan notes A3
|
9/7/2010 | CVIG | Fitch rates Allergan notes A-
|
9/1/2010 | CVIG | Moody's: Allergan unchanged
|
7/21/2010 | CVIG | S&P rates Allergan notes A+
|
4/27/2010 | CVIG | S&P lifts Allergan
|
3/30/2010 | CVIG | Fitch affirms Allergan
|
3/31/2009 | CVIG | Fitch affirms Allergan
|
3/2/2009 | CVIG | Allergan files automatic shelf registration
|
3/17/2008 | CVIG | Fitch affirms Allergan
|